Sun Pharma (SUNPHARMA.NS) share price
Sun Pharma (NSE:SUNPHARMA.NS) last traded at INR 1,915, up 4.70% on the day, with a market cap of INR 459472.6 Cr.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 1,915 |
| 1-day move | +4.70% |
| Market cap | INR 459472.6 Cr |
| Falling Shares risk score | 25/100 (Watch) |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| 1-month move | n/a |
| 1-year move | n/a |
| Statutory auditor | n/a |
| Credit rating | AAA / Stable |
| Promoter pledge | n/a |
Sun Pharmaceutical Industries Limited is India's largest specialty pharmaceutical company, producing high-value generic formulations, active pharmaceutical ingredients, and global dermatology treatments. The enterprise is actively monitored for corporate governance anomalies, working capital stress, debt service coverage, and operational headwinds. Recent trading patterns and financial disclosures reflect ongoing sector adjustments and market-moving developments.
From a regulatory and fiduciary oversight perspective, Sun Pharma is subject to periodic statutory filings, independent financial audits, and regulatory disclosure mandates under NSE listing requirements. Investors and analysts evaluate ongoing risk factors and liquidity reserves prior to making capital allocation decisions.
Governance flags
- Standard Trading Velocity
Coverage of Sun Pharma
Frequently asked questions
Why is Sun Pharma falling today?
Sun Pharma (NSE:SUNPHARMA.NS) is not falling at its latest quote: it is up 4.70% on the day and n/a over one month. See the Key facts and risk sections for longer-term stress signals.
What is the Sun Pharma share price today?
Sun Pharma (NSE:SUNPHARMA.NS) last traded at INR 1,915, a +4.70% move on the day. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the market cap of Sun Pharma?
Sun Pharma has a market capitalisation of about INR 459472.6 Cr at the latest price.
What are the risks of investing in Sun Pharma?
Falling Shares Intelligence rates Sun Pharma 25/100 (Watch) on price stress, volume and disclosure signals; flagged governance items: Standard Trading Velocity. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com